FEATURES
|
|
Posted Mar 13, 2009
 From Chairman and CEO Dr. Daniel Vasella to Head of Pharma, North America, and Novartis Pharmaceuticals CEO Ludwig Hantson, the commitment to diversity and inclusion at Novartis Pharmaceuticals Corp. is very clear. The company has demonstrated strong talent development for women, Blacks, Latinos and Asians, as well as first-rate supplier-diversity initiatives. |
 CEO commitment clearly exists at Novartis. Michelle Gadsden-Williams, vice president and global head of diversity and inclusion, is a direct report to Joseph Jimenez, CEO of Novartis Pharma AG. Marilyn Priestley, vice president and head of diversity and inclusion, ensures that the corporation's U.S. facilities maintain a strong culture of inclusion.
Novartis is retaining its employees and managers at equal levels, regardless of race/ethnicity and gender, which is especially remarkable in this economic climate.One of the key ways Novartis nurtures its top talent is through its exemplary work/life program, including floating religious holidays, paid time off for volunteering/community outreach/professional-association activities, and subsidized membership in wellness or fitness facilities. The company also has excellent benefits for same-sex partners of employees.
Both in the United States and globally, Novartis is committed to values that emphasize diversity. The company has strong diversity training worldwide and has corporate-sanctioned employee groups globally.
Novartis communicates its branding as a diversity leader, getting a perfect score for its diversity presence on its web site. The company also has a vibrant supplier-diversity program, mentoring and educating diverse suppliers and offering them preferred investment-payment terms. |
|
 |
Ludwig Hantson, CEO, Novartis Pharmaceuticals Corp., and Head of Pharma North America
"At Novartis Pharmaceuticals Corp., diversity and inclusion continue to be a top priority irrespective of the economic situation. We have recognized the need to better understand our increasingly diverse customers, whether they are patients, physicians, employers or managed-care organizations, and to build their needs into our strategic plans. By fostering a culture that embraces employee diversity and encourages inclusion, we are better able to adapt to customers' needs." |
 |
Marilyn Priestley, Vice President, Head of Diversity and Inclusion
"We need to reinforce our commitment to diversity and inclusion, especially in these difficult economic times, to demonstrate that our D&I focus is not just a 'nice to have,' but it is truly a business imperative." |
|
Specialty Lists
- No. 9 in The DiversityInc Top 10
Companies for Recruitment & Retention
- No. 8 in The DiversityInc Top 10
Global Diversity Companies
|
Industry
Pharmaceuticals
Main Competitors
Bristol-Myers Squibb, Roche, Sanofi-Aventis
U.S. Headquarters
East Hanover, N.J. |
Number of U.S. Employees
11,592
Annual Revenue
$8.6 billion
% of Operations Outside U.S.
N/A |
 |
|
|
|
|
|
|
